University of California, Davis
Profiles
Home
About
Help/FAQs
History (0)
Search Options
UC Davis
UCI
UCLA
UCSD
UCSF
All UC Health
USC
All
Everything
Research
Concepts
Awards
People
UC Health People
UC Davis People
UCI People
UCLA People
UCSD People
UCSF People
USC People
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Jonathan Riess
Concepts (315)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Acrylamides
Adaptor Proteins, Signal Transducing
Adenocarcinoma
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Albumins
Alleles
Angiogenesis Inhibitors
Aniline Compounds
Animals
Anthracyclines
Antibodies, Bispecific
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antidepressive Agents, Tricyclic
Antigens, CD
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Area Under Curve
Artificial Intelligence
Autoimmune Diseases
Azepines
B7-H1 Antigen
Base Sequence
Benzamides
Benzeneacetamides
Benzimidazoles
Benzoxazoles
beta Catenin
Bevacizumab
Biomarkers, Tumor
Body Mass Index
Body Weight
Bone Neoplasms
Breast Neoplasms
Cachexia
California
Carbazoles
Carboplatin
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Case-Control Studies
CD4 Antigens
CD8-Positive T-Lymphocytes
Cell Line
Cell Line, Tumor
Cell Proliferation
Cetuximab
Chemoradiotherapy
Chemotherapy, Adjuvant
Child
Child, Preschool
Choroid Neoplasms
Circulating Tumor DNA
Cisplatin
Class I Phosphatidylinositol 3-Kinases
Clinical Decision-Making
Clinical Trials as Topic
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Clonal Evolution
c-Mer Tyrosine Kinase
Cohort Studies
Combined Modality Therapy
Computational Biology
Contrast Media
COS Cells
Cranial Irradiation
CTLA-4 Antigen
Cyclin-Dependent Kinases
Cytarabine
Databases, Factual
Deglutition Disorders
Deoxycytidine
Diagnosis, Differential
Discoidin Domain Receptors
Disease Management
Disease Models, Animal
Disease Progression
Disease Susceptibility
Disease-Free Survival
DNA Damage
DNA Helicases
DNA Repair
DNA-Binding Proteins
Drug Administration Schedule
Drug Discovery
Drug Interactions
Drug Repositioning
Drug Resistance
Drug Resistance, Neoplasm
Drug Substitution
Drug-Related Side Effects and Adverse Reactions
Dual Specificity Phosphatase 6
Endonucleases
Endosomes
Enzyme Activation
Ephrins
Epstein-Barr Virus Infections
ErbB Receptors
Erlotinib Hydrochloride
Erythropoietin
Exons
Female
Fluorescent Antibody Technique
Focal Adhesion Kinase 1
Focal Adhesion Protein-Tyrosine Kinases
Follow-Up Studies
Gadolinium
Gadolinium DTPA
Galectin 1
Gastrostomy
Gene Expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Rearrangement
Gene Silencing
Genes, erbB-1
Genes, ras
Genes, Tumor Suppressor
Genomics
Glutamates
Guanine
Head and Neck Neoplasms
HEK293 Cells
HeLa Cells
Hemoglobins
Herpesvirus 4, Human
Heterografts
High-Throughput Nucleotide Sequencing
HIV-1
HLA Antigens
Human papillomavirus 16
Humans
Hypesthesia
Immunoenzyme Techniques
Immunohistochemistry
Immunotherapy
Incidence
Indoles
Induction Chemotherapy
International Cooperation
Isoindoles
Kaplan-Meier Estimate
Kelch-Like ECH-Associated Protein 1
Lactates
Lactoferrin
Liquid Biopsy
Liver Neoplasms
Lung
Lung Neoplasms
Lymphocytes, Tumor-Infiltrating
Magnetic Resonance Imaging
Male
MAP Kinase Signaling System
Maximum Tolerated Dose
Medical Oncology
Melanoma
Meningeal Carcinomatosis
Meningeal Neoplasms
Mesothelioma
Methotrexate
Mice
Mice, Inbred NOD
Mice, SCID
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinases
Molecular Targeted Therapy
Mutation
Myasthenia Gravis
Narcotics
Neoadjuvant Therapy
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasm, Residual
Neoplasms
Neoplasms, Glandular and Epithelial
Neoplastic Cells, Circulating
Neuroendocrine Tumors
NF-E2-Related Factor 2
NIH 3T3 Cells
Nitric Oxide Synthase Type II
Non-Randomized Controlled Trials as Topic
Nuclear Proteins
Oncogene Proteins, Fusion
Oncogenes
Organometallic Compounds
Oropharyngeal Neoplasms
Paclitaxel
Palliative Care
Pancreatic Neoplasms
Papillomaviridae
Paraneoplastic Syndromes
Patient Reported Outcome Measures
Patient Selection
Pemetrexed
Peritoneum
Phosphatidylinositol 3-Kinases
Phosphatidylinositols
Piperazines
Piperidines
Platinum
Pleura
Pleural Neoplasms
Pneumonectomy
Population Groups
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Precision Medicine
Prognosis
Programmed Cell Death 1 Receptor
Proportional Hazards Models
Prospective Studies
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-met
Proto-Oncogene Proteins c-ret
Proto-Oncogene Proteins p21(ras)
Pruritus
Pulmonary Eosinophilia
Pyrazoles
Pyridines
Pyridones
Pyrimidines
Pyrimidinones
Quality of Life
Quinazolines
Quinolones
Radiation Dosage
Radiosurgery
Radiotherapy Dosage
Radiotherapy, Adjuvant
Radiotherapy, Intensity-Modulated
Randomized Controlled Trials as Topic
ras Proteins
Receptor Protein-Tyrosine Kinases
Receptor, Fibroblast Growth Factor, Type 1
Receptor, Notch1
Receptor, Platelet-Derived Growth Factor alpha
Receptors, CCR5
Receptors, Fibroblast Growth Factor
Receptors, G-Protein-Coupled
Receptors, Mitogen
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Recurrence
Registries
Research Design
Response Evaluation Criteria in Solid Tumors
Retreatment
Retrospective Studies
RNA, Antisense
RNA, Messenger
RNA, Small Interfering
RNA, Untranslated
Salvage Therapy
Sequence Analysis, DNA
Sialyltransferases
Signal Transduction
Skin Neoplasms
Small Cell Lung Carcinoma
Social Class
Sodium-Phosphate Cotransporter Proteins, Type IIb
Subcellular Fractions
Sulfones
Survival
Survival Analysis
Survival Rate
Syndecan-4
Terminal Care
Thiadiazoles
Thoracic Neoplasms
Thymectomy
Thymoma
Thymus Gland
Thymus Neoplasms
Tissue Array Analysis
T-Lymphocytes
Tomography, X-Ray Computed
Tonsillar Neoplasms
Topotecan
TOR Serine-Threonine Kinases
Transcription Factors
Transcriptome
Transfection
Treatment Outcome
Triazines
Tumor Burden
Tumor Microenvironment
Tumor Suppressor Proteins
United States
Up-Regulation
Vascular Endothelial Growth Factor A
Virus Integration
Vision Disorders
Weight Loss
Whole Body Imaging
Wnt Signaling Pathway
Xenograft Model Antitumor Assays
Young Adult
Zinc Finger Protein GLI1
Jonathan's Networks
Concepts (315)
Derived automatically from this person's publications.
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Thymus Neoplasms
Acrylamides
Small Cell Lung Carcinoma
Explore
_
Co-Authors (90)
People in Profiles who have published with this person.
Gandara, David
UC Davis
Lara, Primo
UC Davis
Blakely, Collin
UCSF
Singhal, Surbhi
UC Davis
Kelly, Karen
UC Davis
Explore
_
Similar People (60)
People who share similar concepts with this person.
Gandara, David
UC Davis
Garon, Edward
UCLA
Nagasaka, Misako
UCI
Reckamp, Karen
UCLA
Kelly, Karen
UC Davis
Explore
_
Same Department
Giermasz, Adam
Gulati, Shuchi
Lam, Kit
Mitsiades, Nicholas
Wun, Theodore
Search Department
_